Mavyret is intended to treat adults with all types of chronic hepatitis C virus with mild or no cirrhosis who have not previously received treatment for the illness. Patients with moderate to severe ...
MedPage Today on MSN
Study Links Chronic Hep C to Risk of Deadly Cancer
Compared with no HCV infection, chronic HCV was associated with an increased risk of PDAC after adjusting for risk factors including smoking, alcohol use, diabetes, pancreatitis, and liver disease ...
A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic ...
Findings showed that in patients treated with glecaprevir/pibrentasvir, the overall SVR12 rate was 96%, with 0 patients experiencing virologic failure. The Food and ...
Chronic hepatitis C infection has been linked to a higher risk of pancreatic cancer. Learn more about findings from a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback